Concepedia

Raymond D. Blind

RD

16

Publications

1.3K

Citations

14

H-Index

2005

Active since

Affiliations

University of California, San Francisco(Current)

New York University

Vanderbilt University

Vanderbilt University Medical Center

Research Triangle Park Foundation

Raymond D. Blind is an author at University of California, San Francisco specializing in signal transduction, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2005–2024

16

Publications

16

Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression

Weiwei Chen, Thoa Dang, Raymond D. Blind et al. · Molecular Endocrinology · 2008 · 274 citations · Full text

, , +17

Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation

Benjamin C. Lin, Miyuki Suzawa, Raymond D. Blind et al. · Cancer Research · 2009 · 151 citations · Full text

Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes

Raymond D. Blind, Michael J. Garabedian · The Journal of Steroid Biochemistry and Molecular Biology · 2008 · 119 citations · Full text

, , +8

Direct Modification and Activation of a Nuclear Receptor–PIP <sub>2</sub> Complex by the Inositol Lipid Kinase IPMK

Raymond D. Blind, Miyuki Suzawa, Holly A. Ingraham · Science Signaling · 2012 · 118 citations

, , +19

The signaling phospholipid PIP <sub>3</sub> creates a new interaction surface on the nuclear receptor SF-1

Raymond D. Blind, Elena P. Sablin, Kristopher Kuchenbecker et al. · Proceedings of the National Academy of Sciences · 2014 · 98 citations · Full text

Rows per page

1–5 of 16